Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development and Initial Validation of Parent and Child Versions of the Juvenile Arthritis Disease Activity Score Publisher Pubmed



Naddei R1, 2 ; Ridella F3 ; Bovis F4 ; Trincianti C3 ; Avrusin I5 ; Januskeviciute G6 ; Burrone M3 ; Rebollogimenez A1 ; Minden K7, 8 ; Ekelund M9, 10 ; Barone P11 ; Rumbarozenfelde I12 ; Shafaie N13 ; Swart JF14 Show All Authors
Authors
  1. Naddei R1, 2
  2. Ridella F3
  3. Bovis F4
  4. Trincianti C3
  5. Avrusin I5
  6. Januskeviciute G6
  7. Burrone M3
  8. Rebollogimenez A1
  9. Minden K7, 8
  10. Ekelund M9, 10
  11. Barone P11
  12. Rumbarozenfelde I12
  13. Shafaie N13
  14. Swart JF14
  15. Ruperto N15
  16. Ravelli A16
  17. Consolaro A1, 3
Show Affiliations
Authors Affiliations
  1. 1. U.O.C. Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genova, Italy
  2. 2. Dipartimento di Scienze Mediche Traslazionali, Universita degli Studi di Napoli Federico II, Naples, Italy
  3. 3. Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno Infantili (DINOGMI), Universita degli Studi di Genova, Genoa, Italy
  4. 4. Dipartimento di Scienze della Salute (DISSAL), Universita degli Studi di Genova, Genoa, Italy
  5. 5. Department of Hospital Pediatrics, Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation
  6. 6. Centre Medical Pluridisciplinaire Argenteuil, Argenteuil, France
  7. 7. Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charite - Universitatsmedizin Berlin, Freie Universitat Berlin, Humboldt- Universitat zu Berlin, Berlin, Germany
  8. 8. Deutsches Rheuma-Forschungszentrum, Berlin, Germany
  9. 9. Department of Pediatrics, Ryhov County Hospital, Jonkoping, Sweden
  10. 10. Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
  11. 11. Pediatric Rheumatology Unit, Department of integrated Maternal-Child and Reproduction Activity, AOU 'Policlinico-San Marco', Catania, Italy
  12. 12. Faculty of Medicine and Life Sciences, University of Latvia, Riga, Latvia
  13. 13. Department of Pediatrics and Rheumatology, Rheumatology Research Centre, Shariati Hospital, Teheran, Iran
  14. 14. Department of Pediatric Immunology and Rheumatology, Wilhelmina Children's Hospital, Utrecht, Netherlands
  15. 15. UOC Gaslini Trial Centre, Servizio di Sperimentazioni Cliniche Pediatriche, IRCCS Istituto Giannina Gaslini, Genova, Italy
  16. 16. IRCCS Istituto Giannina Gaslini, Genoa, Italy

Source: Rheumatology Published:2025


Abstract

Objective: To develop parent- and child-centred versions of the Juvenile Arthritis Disease Activity Score (JADAS) and to provide preliminary evidence of their validity. Methods: Validation analyses were conducted on two large multinational datasets of patients with juvenile idiopathic arthritis (JIA) and included assessment of construct validity, internal consistency and structure, discriminative validity, responsiveness to change, and predictive validity. Results: The parJADAS and patJADAS include four parent/patient-reported outcomes, each measured on a 0-10 scale: assessment of overall disease activity; rating of pain intensity; assessment of activity of joint disease; and duration of morning stiffness. Both scores are calculated as the simple linear sum of the scores of their four components, which yield for both of them a global score of 0-40. The parJADAS and patJADAS demonstrated good construct validity, yielding high correlations with other JIA composite disease activity measures and moderate correlations with physician global rating and joint counts. Internal consistency was satisfactory, with Cronbach's α > 0.80, and exploratory factor analysis showed that both indices are monodimensional. Both instruments discriminated well between different disease states, with discriminative ability being unaffected by the presence of damage; proved able to predict important disease outcomes; and showed fair responsiveness to clinically important change, with standardized response mean of 0.71. Conclusion: Both parJADAS and patJADAS were found to possess good measurement properties and to serve as a surrogate of physicians' evaluations. Regular home completion of the two instruments through digital technologies offers a suitable and pragmatic approach to deliver remote symptom monitoring and telehealth. © 2024 The Author(s). Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved.